405 related articles for article (PubMed ID: 27804111)
1. Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritis.
Phatak S; Chaurasia S; Mishra SK; Gupta R; Agrawal V; Aggarwal A; Misra R
Clin Exp Immunol; 2017 Mar; 187(3):376-382. PubMed ID: 27804111
[TBL] [Abstract][Full Text] [Related]
2. Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus.
Vincent FB; Kandane-Rathnayake R; Hoi AY; Slavin L; Godsell JD; Kitching AR; Harris J; Nelson CL; Jenkins AJ; Chrysostomou A; Hibbs ML; Kerr PG; Rischmueller M; Mackay F; Morand EF
Lupus; 2018 Nov; 27(13):2029-2040. PubMed ID: 30301439
[TBL] [Abstract][Full Text] [Related]
3. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.
Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF
Lupus; 2013 Aug; 22(9):873-84. PubMed ID: 23846230
[TBL] [Abstract][Full Text] [Related]
4. The relationship between serum A proliferation-inducing ligand and B-cell activating factor levels with disease activity and organ involvement in systemic lupus erythematosus.
Sari S; Cinar S; Yalcinkaya Y; Artim-Esen B; Ozluk Y; Gul A; Ocal L; Deniz G; Inanc M
Lupus; 2022 Apr; 31(5):555-564. PubMed ID: 35249405
[TBL] [Abstract][Full Text] [Related]
5. Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus.
Ortiz-Aljaro P; Montes-Cano MA; García-Lozano JR; Aquino V; Carmona R; Perez-Florido J; García-Hernández FJ; Dopazo J; González-Escribano MF
Sci Rep; 2022 Jul; 12(1):11219. PubMed ID: 35780200
[TBL] [Abstract][Full Text] [Related]
6. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
[TBL] [Abstract][Full Text] [Related]
7. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
8. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
[TBL] [Abstract][Full Text] [Related]
9. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
10. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
Vallerskog T; Heimbürger M; Gunnarsson I; Zhou W; Wahren-Herlenius M; Trollmo C; Malmström V
Arthritis Res Ther; 2006; 8(6):R167. PubMed ID: 17092341
[TBL] [Abstract][Full Text] [Related]
11. APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus.
Eilertsen GØ; Nossent JC
Lupus; 2014 Nov; 23(13):1383-91. PubMed ID: 25057039
[TBL] [Abstract][Full Text] [Related]
12. Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.
Zhao LD; Li Y; Smith MF; Wang JS; Zhang W; Tang FL; Tian XP; Wang HY; Zhang FC; Ba DN; He W; Zhang X
Lupus; 2010 Nov; 19(13):1534-49. PubMed ID: 20974656
[TBL] [Abstract][Full Text] [Related]
13. Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
Ganguly S; Majumder S; Kumar S; Gupta R; Muhammed H; Shobha V; Aggarwal A; Misra R
Lupus; 2020 Nov; 29(13):1800-1806. PubMed ID: 32807020
[TBL] [Abstract][Full Text] [Related]
14. Urinary osteoprotegerin: a potential biomarker of lupus nephritis disease activity.
Gupta R; Aggarwal A; Sinha S; Rajasekhar L; Yadav A; Gaur P; Misra R; Negi VS
Lupus; 2016 Oct; 25(11):1230-6. PubMed ID: 26936893
[TBL] [Abstract][Full Text] [Related]
15. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
[TBL] [Abstract][Full Text] [Related]
16. Nuclear magnetic resonance-based targeted profiling of urinary acetate and citrate following cyclophosphamide therapy in patients with lupus nephritis.
Ganguly S; Kumar U; Gupta N; Guleria A; Majumdar S; Phatak S; Chaurasia S; Kumar S; Aggarwal A; Kumar D; Misra R
Lupus; 2020 Jun; 29(7):782-786. PubMed ID: 32299281
[TBL] [Abstract][Full Text] [Related]
17. Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis.
Aggarwal A; Gupta R; Negi VS; Rajasekhar L; Misra R; Singh P; Chaturvedi V; Sinha S
Clin Exp Immunol; 2017 May; 188(2):254-262. PubMed ID: 28120479
[TBL] [Abstract][Full Text] [Related]
18. Expression of BAFF, APRIL, and cognate receptor genes in lupus nephritis and potential use as urinary biomarkers.
Aguirre-Valencia D; Ríos-Serna LJ; Posso-Osorio I; Naranjo-Escobar J; López D; Bedoya-Joaqui V; Nieto-Aristizábal I; Castro AM; Díaz-Ordoñez L; Navarro EP; Barrera MC; Echeverri A; Cañas CA; Tobón GJ
J Transl Autoimmun; 2020; 3():100027. PubMed ID: 32743512
[TBL] [Abstract][Full Text] [Related]
19. Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men.
Schwarting A; Relle M; Meineck M; Föhr B; Triantafyllias K; Weinmann A; Roth W; Weinmann-Menke J
Lupus; 2018 Feb; 27(2):243-256. PubMed ID: 28659046
[TBL] [Abstract][Full Text] [Related]
20. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity.
Vincent FB; Saulep-Easton D; Figgett WA; Fairfax KA; Mackay F
Cytokine Growth Factor Rev; 2013 Jun; 24(3):203-15. PubMed ID: 23684423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
